Moderna moves to late-stage trial of Covid-19 vaccine candidate
Moderna has received nearly $1bn from the US government under Operation Warp Speed programme
27 July 2020 - 18:13
Bengaluru — Moderna said on Monday it had started a late-stage trial to test the effectiveness of its Covid-19 vaccine candidate, the first such study under the Trump administration's programme to speed development of measures against the novel coronavirus.
News of the study, which will test the response to the vaccine in 30,000 adults who do not have the respiratory illness, pushed shares in Cambridge, Massachusetts-based Moderna up more than 8% before the bell...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.